Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypertension

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 86 articles:
HTML format



Single Articles


    August 2022
  1. CAULDWELL M
    Understanding the implications of hypertensive disorders in pregnancy in women with heart disease.
    Eur Heart J. 2022 Aug 3. pii: 6653698. doi: 10.1093.
    PubMed    


  2. DACHS TM, Duca F, Rettl R, Binder-Rodriguez C, et al
    Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.
    Eur Heart J. 2022 Aug 1. pii: 6652608. doi: 10.1093.
    PubMed     Abstract available


  3. BAUERSACHS J, Olsson KM
    Targeting pulmonary hypertension in patients with heart failure and preserved ejection fraction: rather static than DYNAMIC development?
    Eur Heart J. 2022 Aug 1. pii: 6652609. doi: 10.1093.
    PubMed    


    July 2022
  4. DE SIMONE G, Mancusi C, Hanssen H, Genovesi S, et al
    Hypertension in children and adolescents.
    Eur Heart J. 2022 Jul 27. pii: 6633855. doi: 10.1093.
    PubMed     Abstract available


  5. TADIC M, Cuspidi C, Marwick TH
    Phenotyping the hypertensive heart.
    Eur Heart J. 2022 Jul 23. pii: 6648534. doi: 10.1093.
    PubMed     Abstract available


  6. VERGALLO R, Volpe M
    Long lasting effects of renal denervation: lights and shadows of the SPYRAL HTN-ON MED 3-year follow-up.
    Eur Heart J. 2022;43:2655-2656.
    PubMed    


  7. OMOTE K, Sorimachi H, Obokata M, Reddy YNV, et al
    Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
    Eur Heart J. 2022 Jul 7. pii: 6633254. doi: 10.1093.
    PubMed     Abstract available


  8. HOEPER MM, Rosenkranz S
    Was Paul Wood wrong about pre-capillary pulmonary hypertension protecting against pulmonary congestion in left heart disease?
    Eur Heart J. 2022 Jul 7. pii: 6633248. doi: 10.1093.
    PubMed    


    June 2022
  9. RAMLAKHAN KP, Malhame I, Marelli A, Rutz T, et al
    Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry.
    Eur Heart J. 2022 Jun 21. pii: 6612238. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  10. LUCAS-HERALD AK, Montezano AC, Alves-Lopes R, Haddow L, et al
    Vascular dysfunction and increased cardiovascular risk in hypospadias.
    Eur Heart J. 2022;43:1832-1845.
    PubMed     Abstract available


  11. GALIUTO L, Volpe M
    Treatment of mild hypertension improves pregnancy outcomes.
    Eur Heart J. 2022 May 13. pii: 6585107. doi: 10.1093.
    PubMed    


  12. SCHUTTE AE, Neal B
    The sodium hidden in medication: a tough pill to swallow.
    Eur Heart J. 2022;43:1756-1758.
    PubMed    


    April 2022
  13. VALERIO L, Mavromanoli AC, Barco S, Abele C, et al
    Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
    Eur Heart J. 2022 Apr 28. pii: 6575686. doi: 10.1093.
    PubMed     Abstract available


  14. OJJI D, Aifah A, Dulli L, Iwelunmor J, et al
    Early stakeholder engagement lessons from managing hypertension among people living with human-immunodeficiency virus: an integrated model (MAP-IT).
    Eur Heart J. 2022 Apr 20. pii: 6571044. doi: 10.1093.
    PubMed    


    March 2022
  15. VOLPE M, Patrono C
    Blood pressure lowering drugs differ in their capacity to prevent type 2 diabetes.
    Eur Heart J. 2022;43:1189-1190.
    PubMed    


    February 2022
  16. ZENG C, Rosenberg L, Li X, Djousse L, et al
    Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension.
    Eur Heart J. 2022 Feb 24. pii: 6535634. doi: 10.1093.
    PubMed     Abstract available


  17. RAM CVS
    Renal denervation therapy for hypertension: all that glitters is not gold.
    Eur Heart J. 2022 Feb 15. pii: 6529363. doi: 10.1093.
    PubMed    


  18. VOLPE M, Patrono C
    Age-independent benefits of blood pressure lowering: are they applicable to all patients?
    Eur Heart J. 2022;43:448-449.
    PubMed    


  19. MESSERLI FH, Siontis GCM, Bavishi C, Messerli AW, et al
    Importance of pulse pressure at low systolic blood pressure.
    Eur Heart J. 2022;43:540.
    PubMed    


  20. SPENCE JD, Muller LO, Blanco PJ
    How to identify which patients should not have a systolic blood pressure target of <120 mmHg.
    Eur Heart J. 2022;43:538-539.
    PubMed    


  21. CORRAO G, Mancia G
    Research strategies in treatment of hypertension: value of retrospective real-life data.
    Eur Heart J. 2022 Feb 3. pii: 6520830. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  22. VOLPE M, Patrono C
    Quadruple combination of quarter doses of blood pressure-lowering agents: a string QUARTET in the symphony of hypertension management?
    Eur Heart J. 2021;42:4885-4886.
    PubMed    


  23. VOLPE M, Patrono C
    Another STEP towards tighter control of blood pressure in the elderly.
    Eur Heart J. 2021;42:4715-4716.
    PubMed    


    October 2021
  24. MIHAILIDOU AS, Gulati M
    Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION.
    Eur Heart J. 2021 Oct 18. pii: 6399973. doi: 10.1093.
    PubMed    


  25. BOUCHERON P, Lailler G, Moutengou E, Regnault N, et al
    Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study.
    Eur Heart J. 2021 Oct 13. pii: 6395270. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  26. RUILOPE LM, Valenzuela PL, Lucia A
    Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?
    Eur Heart J. 2021 Sep 27. pii: 6377082. doi: 10.1093.
    PubMed    


  27. CREA F
    The ESC Guidelines on heart failure, sacubitril-valsartan in resistant hypertension, and new therapeutic targets in myocardial hypertrophy.
    Eur Heart J. 2021;42:3581-3585.
    PubMed    


  28. FUKUMOTO Y
    Takayasu arteritis-associated pulmonary hypertension.
    Eur Heart J. 2021 Sep 20. pii: 6372800. doi: 10.1093.
    PubMed    


  29. LINZ D, Gawalko M, Sanders P, Penders J, et al
    Does gut microbiota affect atrial rhythm? Causalities and speculations.
    Eur Heart J. 2021;42:3521-3525.
    PubMed     Abstract available


  30. BAYES-GENIS A, Diez J
    Transition to heart failure in hypertension: going to the heart of the matter.
    Eur Heart J. 2021 Sep 13. pii: 6369562. doi: 10.1093.
    PubMed    


  31. JIANG X, Zhu YJ, Zhou YP, Peng FH, et al
    Clinical features and survival in Takayasu's arteritis-associated pulmonary hypertension: a nationwide study.
    Eur Heart J. 2021 Sep 10. pii: 6368314. doi: 10.1093.
    PubMed     Abstract available


  32. BROWN JM, Zhou W, Weber B, Divakaran S, et al
    Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.
    Eur Heart J. 2021 Sep 7. pii: 6365821. doi: 10.1093.
    PubMed     Abstract available


  33. MESSERLI FH, Bavishi C, Messerli AW, Siontis GCM, et al
    Cerebrotoxicity of antihypertensive therapy in the UK Biobank Cohort Study.
    Eur Heart J. 2021 Sep 4. pii: 6364086. doi: 10.1093.
    PubMed    


    August 2021
  34. KARIO K, Nomura A, Harada N, Okura A, et al
    Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial.
    Eur Heart J. 2021 Aug 29. pii: 6358480. doi: 10.1093.
    PubMed     Abstract available


  35. VOLPE M, Gallo G
    Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension: one shot for a double strike?
    Eur Heart J. 2021 Aug 15. pii: 6352588. doi: 10.1093.
    PubMed    


  36. JACKSON AM, Jhund PS, Anand IS, Dungen HD, et al
    Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
    Eur Heart J. 2021 Aug 15. pii: 6352587. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  37. VOLPE M, Patrono C
    The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profile.
    Eur Heart J. 2021;42:2814-2815.
    PubMed    


    June 2021
  38. VOLPE M, Patrono C
    A SPRINT towards tighter control of blood pressure in hypertension.
    Eur Heart J. 2021 Jun 25. pii: 6309731. doi: 10.1093.
    PubMed    


  39. HE FJ, Campbell NRC, Woodward M, MacGregor GA, et al
    Salt reduction to prevent hypertension: the reasons of the controversy.
    Eur Heart J. 2021 Jun 12. pii: 6297147. doi: 10.1093.
    PubMed     Abstract available


  40. MESSERLI FH, Brguljan J, Rexhaj E, Sever P, et al
    Lowering systolic blood pressure to 120 mmHg or The Lancet's true grit.
    Eur Heart J. 2021;42:2052-2059.
    PubMed    


  41. YAN Y, Mu J
    Salt intake paradox: the estimation method matters.
    Eur Heart J. 2021;42:2133.
    PubMed    


    May 2021
  42. LANDMESSER U, Lehmann I, Eils R
    Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19.
    Eur Heart J. 2021;42:1720-1721.
    PubMed    


    April 2021

  43. Erratum to: A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment.
    Eur Heart J. 2021 Apr 13. pii: 6224359. doi: 10.1093.
    PubMed    


    March 2021
  44. MANNUCCI PM, Ancona C
    Noise and air pollution as triggers of hypertension.
    Eur Heart J. 2021 Mar 22. pii: 6179518. doi: 10.1093.
    PubMed    


  45. VAN DIEPEN S, Armstrong PW
    Learning whether to subtract beta-blockers: it's about time.
    Eur Heart J. 2021;42:915-918.
    PubMed     Abstract available


    February 2021
  46. ESTRUCH R, Ruilope LM, Cosentino F
    The year in cardiovascular medicine 2020: epidemiology and prevention.
    Eur Heart J. 2021;42:813-821.
    PubMed    


  47. WARTOLOWSKA KA, Webb AJS
    Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study.
    Eur Heart J. 2021;42:750-757.
    PubMed     Abstract available


    January 2021
  48. PEREZ DE ISLA L, Watts GF, Alonso R, Diaz-Diaz JL, et al
    Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
    Eur Heart J. 2021 Jan 12. pii: 6091158. doi: 10.1093/eurheartj/ehaa1066.
    PubMed     Abstract available


    December 2020
  49. MESSERLI FH, Bavishi C, Messerli AW, Siontis GCM, et al
    On cerebrotoxicity of antihypertensive therapy and risk factor cosmetics.
    Eur Heart J. 2020 Dec 28. pii: 6054230. doi: 10.1093.
    PubMed    


  50. SALAH HM, Arthur JM, Mehta JL
    Implications of renal ACE2 expression in the age of COVID-19.
    Eur Heart J. 2020;41:4589-4591.
    PubMed    


  51. CREA F
    Focus on hypertension but also on the 'the digital twin' and on kidney function and disease.
    Eur Heart J. 2020;41:4531-4534.
    PubMed    


  52. LA GERCHE A
    Proof that exercise works, now it's time for optimizing delivery to our patients with pulmonary hypertension.
    Eur Heart J. 2020 Dec 12. pii: 6031923. doi: 10.1093.
    PubMed    


    November 2020
  53. GRUNIG E, MacKenzie A, Peacock AJ, Eichstaedt CA, et al
    Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial.
    Eur Heart J. 2020 Nov 24. pii: 6000268. doi: 10.1093.
    PubMed     Abstract available



  54. Relates to: 'Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction: Hygia Chronotherapy Trial' by Ramon C. Hermida et al. Eur Heart J 2020; https://doi.org/10.1093/eurheartj/ehz754.
    Eur Heart J. 2020 Nov 22. pii: 5998316. doi: 10.1093.
    PubMed    


  55. LIEW CH, McEvoy JW
    The diastolic blood pressure J-curve remains an observational research phenomenon that has not yet been proven as causal and should not be used to make invasive treatment decisions.
    Eur Heart J. 2020;41:4284-4285.
    PubMed    


  56. GUO TT, Tan JS, Wu Y, Gao X, et al
    Balloon pulmonary angioplasty with distal embolic protection device for chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2020 Nov 12. pii: 5979515. doi: 10.1093.
    PubMed    


  57. VOLPE M, Patrono C
    Decline in blood pressure control trends in the US: a real step back: Comment on National Health and Nutrition Examination Survey (NHANES) data.
    Eur Heart J. 2020;41:3986-3987.
    PubMed    


    October 2020
  58. JIANG X, Eales JM, Scannali D, Nazgiewicz A, et al
    Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney.
    Eur Heart J. 2020 Oct 27. pii: 5940440. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  59. VENKATA C, Ram S
    Dr Norman M. Kaplan (1931-2020): a giant in the field of hypertension has departed.
    Eur Heart J. 2020 Sep 25. pii: 5911422. doi: 10.1093.
    PubMed    


    July 2020
  60. VOLPE M, Battistoni A
    Genes and hypertension: stepping into the secret through the arterial wall.
    Eur Heart J. 2020 Jul 29. pii: 5877875. doi: 10.1093.
    PubMed    


  61. ESCANED J, Lerman LO
    Coronary microcirculation and hypertensive heart failure.
    Eur Heart J. 2020;41:2376-2378.
    PubMed    


    June 2020
  62. ROMMEL KP, Lurz P
    Transcatheter tricuspid valve repair and pulmonary hypertension: navigating through troubled waters.
    Eur Heart J. 2020 Jun 30. pii: 5865477. doi: 10.1093.
    PubMed    


  63. D'ALTO M, Naeije R
    Transcatheter tricuspid valve repair in patients with pulmonary hypertension.
    Eur Heart J. 2020 Jun 30. pii: 5865473. doi: 10.1093.
    PubMed    


  64. RUILOPE LM, Tamargo J, Ruiz-Hurtado G
    Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.
    Eur Heart J. 2020 Jun 4. pii: 5851433. doi: 10.1093.
    PubMed    


  65. GAO C, Cai Y, Zhang K, Zhou L, et al
    Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.
    Eur Heart J. 2020 Jun 4. pii: 5851436. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  66. ZHU WW, Lv XZ, Li WH
    Hereditary haemorrhagic telangiectasia with heritable pulmonary arterial hypertension.
    Eur Heart J. 2020 May 26. pii: 5846239. doi: 10.1093.
    PubMed    


    April 2020
  67. KUSTER GM, Osswald S
    Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence.
    Eur Heart J. 2020 Apr 23. pii: 5824224. doi: 10.1093.
    PubMed    


  68. CIULLA MM
    Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19.
    Eur Heart J. 2020 Apr 23. pii: 5824223. doi: 10.1093.
    PubMed    



  69. Relates to: 'Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction: Hygia Chronotherapy Trial'.
    Eur Heart J. 2020;41:1600.
    PubMed    


  70. LUSCHER TF
    Unanswered questions in hypertension: prematurity and long-term trajectories, masked and white coat hypertension.
    Eur Heart J. 2020;41:1527-1530.
    PubMed    


  71. HERMIDA RC, Mojon A, Fernandez JR
    Comparing the design of the primary-care based Hygia Chronotherapy Trial and the Internet-Based TIME Study.
    Eur Heart J. 2020;41:1608.
    PubMed    


  72. HERMIDA RC, Crespo JJ, Dominguez-Sardina M
    Improved reduction of cardiovascular risk by bedtime ingestion of ARB and ACEI medication class therapies.
    Eur Heart J. 2020;41:1602-1603.
    PubMed    


  73. KELM M
    Early birth affects vascular function.
    Eur Heart J. 2020;41:1551-1553.
    PubMed    


  74. GUTHRIE G, Poulter N, Macdonald T, Ford I, et al
    Chronotherapy in hypertension: the devil is in the details.
    Eur Heart J. 2020 Apr 19. pii: 5822566. doi: 10.1093.
    PubMed    


  75. SANCHEZ-SANCHEZ C, Lopez-Caballero C, Contreras I, Puerto B, et al
    Is bedtime treatment appropriate for all hypertensive patients?
    Eur Heart J. 2020 Apr 18. pii: 5822039. doi: 10.1093.
    PubMed    


  76. HERMIDA RC, Fernandez JR, Mojon A
    Chronotherapy of hypertension, asleep ambulatory blood pressure, and glaucoma.
    Eur Heart J. 2020 Apr 18. pii: 5822040. doi: 10.1093.
    PubMed    


  77. SEN S, Kaskal M, Uresin Y
    Chrono-pharmacological effects of antihypertensive drugs.
    Eur Heart J. 2020 Apr 16. pii: 5820905. doi: 10.1093.
    PubMed    


  78. LARSON S, Cho MC, Tsioufis K, Yang E, et al
    2018 Korean Society of Hypertension Guidelinefor the Management of Hypertension: A Comparison of American, European, and Korean Blood Pressure Guidelines.
    Eur Heart J. 2020;41:1384-1386.
    PubMed    


    March 2020
  79. ZHOU W, Brown JM, Bajaj NS, Chandra A, et al
    Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure.
    Eur Heart J. 2020 Mar 28. pii: 5813079. doi: 10.1093.
    PubMed     Abstract available


  80. JACOBSEN AP, Al Rifai M, Arps K, Whelton SP, et al
    A cohort study and meta-analysis of isolated diastolic hypertension: searching for a threshold to guide treatment.
    Eur Heart J. 2020 Mar 2. pii: 6157020. doi: 10.1093.
    PubMed     Abstract available


  81. COCA A
    Blood pressure and cardiovascular disease: are diastolic values 80-89 mmHg enough to define hypertension?
    Eur Heart J. 2020 Mar 2. pii: 6157019. doi: 10.1093.
    PubMed    


  82. BOHM M, Ferreira JP, Mahfoud F, Duarte K, et al
    Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.
    Eur Heart J. 2020 Mar 2. pii: 5771273. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  83. ZHOU Y, Wen J, Nie J
    How much can acute heart failure patients with low basic blood pressure (systolic blood pressure 90-100 mmHg) benefit from the use of vasodilators?
    Eur Heart J. 2020 Jan 10. pii: 5700445. doi: 10.1093.
    PubMed    


    November 2019
  84. LUSCHER TF
    Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
    Eur Heart J. 2019;40:3579-3582.
    PubMed    


    May 2019
  85. SHARASHOVA E, Wilsgaard T, Ball J, Morseth B, et al
    Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromso Study.
    Eur Heart J. 2019 May 3. pii: 5485289. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  86. CHAO TF, Lip GYH, Lin YJ, Chang SL, et al
    Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.
    Eur Heart J. 2019 Jan 2. pii: 5272355. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: